Stockscreener 앱 받기
17.12
0.88%
0.15
전일 마감가:
$16.97
열려 있는:
$16.99
하루 거래량:
1.58M
Relative Volume:
0.71
시가총액:
$4.86B
수익:
$1.11B
순이익/손실:
$24.82M
주가수익비율:
214.00
EPS:
0.08
순현금흐름:
$105.89M
1주 성능:
-3.55%
1개월 성능:
-9.80%
6개월 성능:
+8.91%
1년 성능:
+27.48%
1일 변동 폭
$16.72
$17.43
1주일 범위
$16.64
$17.72
52주 변동 폭
$9.53
$19.85
소테라헬스 Stock (SHC) Company Profile
명칭
Sotera Health Co
전화
440-262-1410
주소
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
17.12 | 4.82B | 1.11B | 24.82M | 105.89M | 0.08 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
소테라헬스 Stock (SHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | 재개 | RBC Capital Mkts | Outperform |
| 2025-12-18 | 개시 | William Blair | Outperform |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-05-05 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-12-06 | 개시 | Goldman | Neutral |
| 2024-05-21 | 개시 | Piper Sandler | Neutral |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-03-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-01-11 | 업그레이드 | Barclays | Underweight → Overweight |
| 2023-01-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-09-20 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-09 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-03-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-14 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Citigroup | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | JP Morgan | Overweight |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
소테라헬스 주식(SHC)의 최신 뉴스
Sotera Health Company (NASDAQ:SHC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Sotera Health (NASDAQ:SHC) Increases Its Impact In Nasdaq Today Medical Market - Kalkine Media
Former Timken CEO joins board of Sotera Health - Crain's Cleveland Business
Sotera Health appoints Richard Kyle to board - Medical Buyer
Sotera Health Appoints New Independent Director - Intellectia AI
Former Timken CEO joins Sotera Health board after 2014-24 run - Stock Titan
Is Sotera Health (SHC) Pricing Looked At Again After Recent Pharma Biotech Reassessment? - Yahoo Finance
Sotera Health Company (SHC) Stock Analysis: A Promising 11.68% Potential Upside for Investors - DirectorsTalk Interviews
Sotera Health Company's (NASDAQ:SHC) institutional investors lost 3.1% last week but have benefitted from longer-term gains - simplywall.st
Sotera Health Company (SHC) Stock Analysis: A 9.94% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews
Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and a Promising 6.56% Upside - DirectorsTalk Interviews
Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside - DirectorsTalk Interviews
Is It Time To Reassess Sotera Health (SHC) After Its Strong One Year Share Price Gain? - Yahoo Finance
Dip Buying: Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 News Drivers & Fast Entry High Yield Stock Tips - Bộ Nội Vụ
Sterilization Services MarketGlobal Forecast 2025-2032: - GlobeNewswire
Sotera Health to Seek M&A Opportunities - marketscreener.com
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sotera Health to Showcase Continued Revenue Growth and - GlobeNewswire
Sotera Health Shows Market Leadership With Jump To 83 RS Rating - MSN
Sotera Health (NASDAQ:SHC) Rating Increased to Moderate Buy at Royal Bank Of Canada - MarketBeat
SHC: Sotera Health Receives 'Outperform' Rating from RBC Capital - GuruFocus
Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand - Investing.com Nigeria
Piper Sandler upgrades Sotera Health stock rating to Overweight on improved demand By Investing.com - Investing.com South Africa
Piper Sandler Upgrades Sotera Health (SHC) with a New Target Pri - GuruFocus
Sotera Health (SHC) Receives Positive Outlook with Strong Growth Potential - GuruFocus
Is Sotera Health Company (NASDAQ:SHC) Potentially Undervalued? - simplywall.st
RBC Capital initiates Sotera Health stock with Outperform rating By Investing.com - Investing.com Canada
Will Sotera Health Company stock keep outperforming rivalsJuly 2025 Momentum & Capital Efficient Trading Techniques - Улправда
Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - AOL.com
Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million - The Motley Fool
Form 424B7Prospectus [Rule 424(b)(7)] - ADVFN
Form 8-KCurrent report - ADVFN
RBC Capital initiates Sotera Health stock with Outperform rating - Investing.com
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Sotera Health (NASDAQ:SHC) Sets New 12-Month HighTime to Buy? - MarketBeat
Sotera Health Inc (NASDAQ:SHC) Nasdaq Futures Quality Systems - Kalkine Media
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 31% Undervalued - Yahoo Finance
Sotera Health (NASDAQ:SHC) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Sotera Health Co stock hits 52-week high at 17.83 USD - Investing.com
Sotera Health (NASDAQ:SHC) Sets New 1-Year High – Still a Buy? - Defense World
Sotera Health (NASDAQ:SHC) Hits New 1-Year HighShould You Buy? - MarketBeat
Sotera Health Co stock hits 52-week high at $17.79 By Investing.com - Investing.com Nigeria
Sotera Health Co stock hits 52-week high at $17.79 - Investing.com
Sotera Health Company (NASDAQ:SHC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sotera Health Company (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Q3 Research Tools & Consumables Earnings: Sotera Health Company (NASDAQ:SHC) Earns Top Marks - Yahoo Finance
Sotera Health (NASDAQ:SHC) versus Surgery Partners (NASDAQ:SGRY) Financial Review - Defense World
1 Small-Cap Stock to Target This Week and 2 We Ignore - Finviz
Is Sotera Health Company stock undervalued vs historical averagesJuly 2025 Opening Moves & Safe Capital Investment Plans - Улправда
Stock Report: Will Sotera Health Company stock benefit from green energy trendsQuarterly Investment Review & AI Based Buy and Sell Signals - Улправда
소테라헬스 (SHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
소테라헬스 주식 (SHC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
315,896 |
5,196,489 |
552,790 |
0.00%
1.13%
자본화:
|
볼륨(24시간):